|
FES-I Members of WP2 and WP4 initially carried out a systematic review of the literature on measures of fear of falling [link to paper measuring the psychological outcomes of falling] and two workshops in this topic, with invited experts from across Europe. We concluded that the Falls Efficacy Scale (FES) was the best validated measure currently available, but had some limitations, especially for use in different languages and cultures. We have therefore developed the Falls Efficacy Scale International (FES-I) [link to paper on the Development and initial validation of the Falls Efficacy Scale-International (FES-I)], which has initially proven just as reliable and a little more sensitive to between group differences than the original FES. The FES-I has been further validated in German and Dutch, and translated into Swiss French, Norwegian, Spanish and Greek. We are now carrying out studies to assess its sensitivity to change following an intervention. We will also be recommendations for how to manage fear of falling, based on a review of the literature. NEW: FES-I has now been translated into Urdu, Hindi and Punjabi; to download these translations please visit the UK page. FES-I Translations are available for free download to registered users from the Find a FES-I Page. The following documents are also available that may be of interest: Translation/interviewer notes in English. Translation protocol in English. Development of the FES-I in English. The AFRIS is also available from Work Package 4 All content within ProFaNE web site is provided for general information only, and should not be treated as a substitute for the medical advice of your own doctor or any other health care professional. Health care professionals using the web site do so at their own risk. ProFaNE is not responsible or liable for any diagnosis made by a user including any health care professional based on the content of the ProFaNE website. ProFaNE is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites. See our web site Legal and Privacy notice for more information.
|